SCHEMBL30007110

SCHEMBL30007110

CCOC(=O)c1sc(Nc2nc(N3CCN(C)CC3)cc(N3CCNC(=O)C3)n2)nc1C

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 6/20 0.65
MAPT P10636 5/20 0.51
KDM4E B2RXH2 5/20 0.51
ALDH1A1 P00352 4/20 0.51
LMNA P02545 3/20 0.48
DHODH Q02127 5/20 0.44
NPC1 O15118 1/20 0.44
HPGD P15428 1/20 0.44
RAB9A P51151 1/20 0.44
NPSR1 Q6W5P4 2/20 0.43
CCNT1 O60563 1/20 0.42
CDK4 P11802 1/20 0.42
CCND1 P24385 1/20 0.42
CCND3 P30281 1/20 0.42
CDK9 P50750 1/20 0.42
CDK6 Q00534 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL290367 1.00 PDE5A (0.65) PDE5AMAPTKDM4EALDH1A1LMNA
SCHEMBL290735 0.90 PDE5A (0.78) PDE5AMAPTKDM4EALDH1A1LMNA
SCHEMBL30006503 0.90 PDE5A (0.82) PDE5AMAPTKDM4EALDH1A1LMNA
SCHEMBL290893 0.90 PDE5A (0.82) PDE5AMAPTKDM4EALDH1A1LMNA
SCHEMBL2679613 0.87 PDE5A (0.59) PDE5AMAPTKDM4EALDH1A1LMNA
SCHEMBL291604 0.87 PDE5A (0.70) PDE5AMAPTKDM4EALDH1A1LMNA
SCHEMBL29832127 0.87 PDE5A (0.70) PDE5AMAPTKDM4EALDH1A1LMNA
SCHEMBL29832436 0.86 PDE5A (0.62) PDE5AMAPTKDM4EALDH1A1LMNA
SCHEMBL28565189 0.86 PDE5A (0.62) PDE5AMAPTKDM4EALDH1A1LMNA
SCHEMBL290241 0.85 PDE5A (0.68) PDE5AMAPTKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4572765-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE Mitodicure GmbH (DE) 2025-06-25 EP disclosed
WO-2024038089-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE MITODICURE GMBH (DE) 2024-02-22 WO disclosed
CN-115192711-A Use of PDE7 inhibitors for the treatment of movement disorders 奥默罗斯公司 2022-10-18 CN disclosed